Tocilizumab: A Role for Biomarker-Directed Therapy? | Crit Care Med;50(3): 510-513, 2022 03 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Tocilizumab: A Role for Biomarker-Directed Therapy?

Strich, Jeffrey R; Chertow, Daniel S.

Strich JR; Department of Critical Care Medicine, National Institutes of Health Clinical Center, Bethesda, MD.
Chertow DS; United States Public Health Service Commissioned Corps, Rockville, MD.

Crit Care Med ; 50(3): 510-513, 2022 03 01.

Article in English | MEDLINE | ID: covidwho-1713751

Subject(s)

Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Humanized/therapeutic use; Biomarkers

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized Type of study: Prognostic study Language: English Journal: Crit Care Med Year: 2022 Document Type: Article Affiliation country: CCM.0000000000005281

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized Type of study: Prognostic study Language: English Journal: Crit Care Med Year: 2022 Document Type: Article Affiliation country: CCM.0000000000005281